Multidrug resistance as a cause of cytotoxic drug failure

Pharmaceutical Journal

Volumn 257, Issue 6907, 1996, Pages 294-296

  Holmes, Julie ^a  

^a Hadley Hutt Computing Ltd   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; CHLORMETHINE; CISPLATIN; COLCHICINE; CYCLOPHOSPHAMIDE; CYTARABINE; CYTOTOXIC AGENT; DACTINOMYCIN; DIHYDROFOLATE REDUCTASE; DOXORUBICIN; ETHIDIUM BROMIDE; ETOPOSIDE; FOLIC ACID ANTAGONIST; GLYCOPROTEIN P; METHOTREXATE; PHENOTHIAZINE; PROGESTERONE; QUINIDINE; TAMOXIFEN; TERFENADINE; VALINOMYCIN; VALSPODAR; VERAPAMIL; VINBLASTINE; VINCRISTINE;

APOPTOSIS; CANCER; CLINICAL TRIAL; DRUG MECHANISM; DRUG METABOLISM; DRUG PROTEIN BINDING; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; LEUKEMIA; LYMPHOMA; MULTIDRUG RESISTANCE; SHORT SURVEY; TREATMENT FAILURE;

EID: 0029820506     PISSN: 00316873     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (21)

1. Chabner BA. Clinical strategies for cancer treatment: the role of drugs. In: Chabner BA, Collins, JM, editors. Cancer chemotherapy: principles and practice. Philadelphia: Lippincott Co, 1990:1-15
2. Endicott JA, Ling V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Ann Rev Biochem 1989;58:137-71.
3. Gottesman MM, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Ibid 1993;62.385-427.
4. Goldie JH, Krystal G, Hartley D, et al. A methotrexate insensitive variant of folate reductase present in two lines of methotrexate resistant L5178Y cells. Eur J Cancer 1980;16:1539-46.
5. Schimke RT. Gene amplification, drug resistance and cancer. Cancer Res 1984;44:1735-42.
6. Beck WTJ. Unknotting the complexities of MDR: the involvement of DNA topoisomerases in drug action and resistance. J Natl Cancer Inst 1989;81:1683-5.
7. Arrick BA, Nathan CF. Glutathione metabolism as a determinant of therapeutic efficacy. Cancer Res 1984;44:4224-32.
8. Russo A, De Graf, W, Friedman N, et al. Selective modulation of glutathione levels in human normal versus tumour cells and subsequent differential response to chemotherapy drugs. Ibid 1986;46:2845-8.
9. Fisher TC, Milner AE, Gregory CD, et al. Bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways. Ibid 1993;53:3321-6.
10. Biedler JL, Riehm H. Cellular resistance to actinomycin D in Chinese hamster cells in vitro: Cross resistance, radioautographic and cytogenetic studies. Ibid 1970;30:1174-84.
11. Dano K. Active outward transport of daunomycin in Erlich ascites tumour cells. Biochim Biophys Acta 1973;323:466-83
12. Ling V, Thompson LH. Reduced permeability in CHO cells as a mechanism of resistance to colchicine J Cell Physiol 1974;83.103-16.
13. Juliano RL, Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 1976;453:152-62.
14. Wilson CM. Amplification of a gene related to mammalian mdr genes in drug resistant Plasmodium falciparum. Science 1989;244:1184-6.
15. Riordan JR, Rommens JM, Kerem, B-S, et al. Identification of the cystic fibrosis gene: cloning and characterisation of complementary DNA. Ibid 1990;245:1066-73.
16. Willingham MC, Cornwall MM, Cardarelli CO, et al. Drug-cell analysis of daunoru-bicin uptake and efflux in multidrug resistant and sensitive KB cells: effects of verapamil and other drugs. Cancer Res 1986;46:5941-6.
17. Thiebaut F, Tsuruo T, Hamada H, et al. Cellular localisation of the multidrug resistance gene product P-glycoprotein in normal tissues. Proc Natl Acad Sci USA 1987;84:7735-8,
18. Tsuruo T, Iida H, Tsukagoshi S, et al. Overcoming of vincristine resistance in P388 leukaemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 1981;44:4303-7.
19. Safa AR Photoaffinity labelling of the multidrug resistance-related P-glycoprotein with photoaffinity analogues of verapamil. Proc Natl Acad Sci USA 1988,85:7187-91.
20. Zamora JM, Pearce HL, Beck WT. Physical-chemical properties shared by compounds that modulate MDR in human leukaemic cells. Mol Pharmacol 1988;33:454-62.
21. Gaveriaux C, Boesch B, Jachez B, et al. PSC-833, a non-immunosuppressive cyclosporin analogue, is a potent multidrug resistance modifier. J Cell Pharmacol 1991;2:225-34